Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by lovetheoilpatchon Feb 23, 2015 2:34am
92 Views
Post# 23453817

RE:RE:RE:RE:wits and witless

RE:RE:RE:RE:wits and witlessWell craig henry...its a valid point ....do you have an answer ?..or are you just gonna tell people to.sell and insult people??...you know like a pumper does.....if this is so pivotal to us shareholders. ..dont you think we would have heard something from the "scarpata" study???....lots of hype about the b4b presentation was made before it went down.....and well weve heard nothing......you have been around buddy...no news isnt always good news....
Bullboard Posts